Vital Images’ 510(k) FDA-cleared computed tomography (CT) myocardial perfusion application is debuting at the 10th Annual Scientific Meeting of the Society of Cardiovascular Computed Tomography (SCCT; 16–19 July, Las Vegas).
Cardiac CT procedures are performed to determine the function of the myocardium. Vital’s CT myocardial perfusion application enables physicians to visualise and analyse the heart’s blood flow using data collected during cardiac CT scans. It provides semi-automatic measurements, segmentation of the myocardium, calculation of perfusion results and detailed perfusion polar maps. CT myocardial perfusion evaluation can be combined with cardiac CT angiography in a single examination to assess patients with acute chest pain.
“Cardiologists have been using Vital solutions to help visualise anatomy and determine treatment plans for years,” said Jim Litterer, general manager at Vital. “We are pleased that we now can offer our global customers technology to aid in myocardial perfusion visualisation and analysis.”
Vital’s CT myocardial perfusion was developed using feedback gathered from industry experts who also participated in the CORE 320 study, led by Toshiba Medical Systems, which used Toshiba’s Aquilion One to determine the effectiveness of 320-detector row dynamic volume CT to single-photon emission computed tomography (SPECT) technology. It showed that cardiac CT angiography findings more closely predict whether a patient undergoes revascularisation than results generated with SPECT.
Attendees at the SCCT meeting in Las Vegas can experience CT myocardial perfusion hands-on during a workshop led by Richard T George and at Vital’s booth #501.